Patents Assigned to Suzhou Sirnaomics Biopharmaceuticals Co., Ltd.
  • Gemcitabine Derivatives for Cancer Therapy
    Publication number: 20200108089
    Abstract: The present invention provides pharmaceutical compositions comprising the chemotherapy drug gemcitabine (GEM) and certain derivatives, a taurocholic acid (TCA) formulation, and a Histidine-Lysine Polymer (HKP) conjugate, for enhancement of RNAi cancer therapeutics.
    Type: Application
    Filed: March 19, 2018
    Publication date: April 9, 2020
    Applicants: Suzhou Sirnaomics Biopharmaceuticals Co., Ltd., Sirnaomics, Inc.
    Inventors: Patrick Y. Lu, Aslam Ansari, Parker J. Guan, John J. Xu, Vera Simonenko, Tom Zhong